The following is a statement from biopharmaceutical company Merck regarding a global shortage of BCG, a medication used in the treatment of bladder cancer:Since 2012, when Merck unexpectedly became ...
BECAUSE OF IT. IS THERE A SHORTAGE? >> THERE IS. >> DOCTOR BILL SANTIS HAS BEEN A UROLOGIST AND CANCER SURGEON AT CONCORD HOSPITAL FOR 22 YEARS. HE SAYS THIS BCG SHORTAGE IS WORLDWIDE, MAKING IT TOUGH ...
CHICAGO — Use of the Connaught strain of bacillus Calmette-Guérin, an adjuvant immunotherapy used in the treatment of non-muscle-invasive bladder cancer, significantly reduced cancer recurrence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results